SEC Form 4 · accession 0000899243-17-024166
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
KONINKLIJKE PHILIPS NV
10% Owner
Period of report
Oct 11, 2017
Accepted (ET)
Oct 13, 2017 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Oct 11, 2017 | X | 4,728,191 | $1.06 | A | 29,693,444 | D | |
| Common Stock, par value $0.0001 per share | Oct 11, 2017 | S | 3,334,586 | $1.503 | D | 26,358,858 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $1.06 | Oct 11, 2017 | X | 4,728,191 | D | Aug 12, 2014 | Oct 11, 2017 | Common Stock, par value $0.0001 per share | 4,728,191 | 0 | D |
Explanation of responses
- F1On October 11, 2017, the reporting person exercised a warrant to purchase 4,728,191 shares of common stock of Corindus Vascular Robotics, Inc. (the "Company"), par value $0.0001 per share, for $1.06 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 3,334,586 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,393,605 shares.